Tecentriq Hybreza, a subcutaneous delivery of the drug, was approved for certain types of sarcoma, in addition to lung, skin and liver cancers. The Food and Drug Administration (FDA) approved ...
The US Food and Drug Administration (FDA) has approved atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc.) as a subcutaneous injection in adults, covering all approved indications ...
Kalbitor (ecallantide) is a brand-name drug that’s prescribed for hereditary angioedema attacks in adults and some children. Kalbitor comes as a liquid that’s given as a subcutaneous injection by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback